National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Late Effects of Treatment for Childhood Cancer (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 03/26/2008
Table 1. Common Agents Associated With Therapy Late Effects

Agent/Agent Class/Modality  Affected Body System 
Anthracyclines Circulatory (Cardiac)
Respiratory (Pulmonary)
Alkylating agents Reproductive (Gonadal)
Second malignant neoplasms
Topoisomerase II inhibitors Second malignant neoplasms
Platinums Urinary (Renal)
Special senses (Hearing)
Second malignant neoplasms
Corticosteroids Central nervous system
Musculoskeletal (Bone and body composition)
Musculoskeletal (Obesity)
Intrathecal chemotherapy Central nervous system
Bleomycin Respiratory (Pulmonary)
Methotrexate Central nervous system
Vincristine Digestive (Dental)
Thioguanine Digestive (Hepatic)


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov